Evidence map›Paper›PMID 34230878›Full record

ArticleAfrican journal of laboratory medicine2021

Molecular characterisation of

Jean F Kloppers, André de Kock, Johané Cronjé, Anne-Cecilia van Marle

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in African journal of laboratory medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Clinical profile ofMolecular biology research communications · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jean F KloppersDepartment of Haematology and Cell Biology, School of Pathology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.ORCID https://orcid.org/0000-0002-8148-1242
André de KockDepartment of Haematology and Cell Biology, School of Pathology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.ORCID https://orcid.org/0000-0002-2910-1273
Johané CronjéDepartment of Haematology and Cell Biology, School of Pathology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.ORCID https://orcid.org/0000-0003-0662-7384
Anne-Cecilia van MarleDepartment of Haematology and Cell Biology, School of Pathology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.ORCID https://orcid.org/0000-0002-6569-4061
National Health Laboratory Service · ZAUniversity of the Free State · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecognition of molecular abnormalities in acute myeloid leukaemia (AML) has improved our understanding of its biology.

objectiveThis study described the prevalence and molecular characteristics of the

methodsThe study included 40 de novo AML patients. An

resultsThe patients' median age was 38.5 years, with 77.5% (

conclusion

Indexed as

acute myeloid leukaemiaAMLFLT3-ITDfrequencyNPM1South Africa

Identifiers

PMID34230878
PMCPMC8252134
OpenAlexW3178207702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.